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cyanoacrylateAbstract Objective: To evaluate using of polyvinyl alcohol particle and N-butyl cyanoacrylate
(NBCA)/lipiodol mixture for selective embolization of eight patients with ruptured renal angiomyo-
lipomas (AMLs).
Patients and methods: From January 2006 to December 2012, eight patients underwent angiogra-
phy and embolization of renal angiomyolipoma-associated hemorrhage. The patients were 7 women
and one man, 22–52 years old. Only 2 patients had the sporadic form of angiomyolipoma and the
other 6 patients had the tuberous sclerosis form. Two patients presented with hematuria, while
the other 6 patients presented with perinephric bleed. Three patients were treated urgently, while
the other 5 patients were scheduled for embolization 1–3 days after admission. The technical and
clinical success, complications, rebleeding and the need for surgical intervention were documented.
Results: Angiography showed aneurysmal dilatation in 7 patients (88%). Twenty-ﬁve feeding
arteries were embolized. Primary technical success rate was 62.5% and the clinical success rate
was 100%. No major complications or deaths occurred during or after the procedures. Mean
hospitalization was 5 (range 3–12) days. Secondary technical success rate was 100%. No tumor
growth on the follow up CT and the mean size reduction was 41%.
Conclusion: Selective arterial embolization with polyvinyl alcohol particles and N-butyl cyanoac-
rylate/lipiodol mixture is an effective and safe treatment for patients with ruptured renal AMLs.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
There are two types of angiomyolipomas (AMLs); the ﬁrst is
the more common sporadic type representing 80% of all
AMLs, and the second type is the AML associated with
tuberous sclerosis (TS) that represents the remaining 20% of
AMLs (1,2). AML was described as the most common cause
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into the perinephric space. Rarely, AMLs rupture into the
renal collecting system causing hematuria. It was reported that
50–60% of AMLs measuring 4 cm or more bleed spontane-
ously (2), and that the larger the tumor, the greater is the risk
of bleeding. So, it is generally agreed that patients with asymp-
tomatic AML larger than 4 cm should be treated, as should
those with symptomatic lesions of any size (4). The bleeding
tendency originates from the abnormal aneurysmal tortuous
blood vessels that constitute the angiogenic component of
the tumor (5), therefore, angioembolization has become
increasingly widespread for treatment of AML-associated
bleeding. This study was performed to report our experience
in treating 8 patients having AML associated with
hemorrhage, with selective arterial embolization (SAE) using
polyvinyl alcohol particles (PVA) particles and N-butyl
cyanoacrylate (NBCA)/lipiodol mixture.
2. Patients and methods
Institutional review board approval was obtained for this ret-
rospective study. From January 2006 to December 2012, eight
patients were referred for angiography and embolization of
renal AML-associated hemorrhage. The patients were 7
women and one man, 22–52 years old (mean age, 36 years).
Only 2 patients had the sporadic form of AML and the other
6 patients had the TS form. Two patients presented with hema-
turia, while the other 6 (75%) patients presented with peri-
nephric bleed. Of this later group, one patient presented with
bilateral large AML and left perinephric bleed and underwent
bilateral AMLs embolization in the same session. The patients
were initially examined with ultrasound (US), then the pres-
ence of AMLs was conﬁrmed by unenhanced and enhanced
computed tomography (CT).We relied on observation of lipo-
matous density within the tumor to diagnose AML. Also the
retroperitoneal hematoma was identiﬁed on both US and
CT. Patients presented with hematuria, underwent cysto-
uretroscopy to identify the bleeding side. The patients were
treated initially with infusion of packed red blood cells for
hemodynamic instability. SAE was indicated either to control
severe hemorrhage from AML in hemodynamically unstable
patients, or to prevent rebleeding in stable patients. Only three
patients were treated urgently, at the same day, due to hemo-
dynamic instability, while the other 5 patients were scheduled
for embolization 1–3 days after admission. The technical
success of the procedure was documented by postprocedural
control angiogram. It was deﬁned as the ability to perform
total devascularization of the AML. The clinical success was
documented by the ability of the SAE to stop bleeding based
on disappearance of gross fresh hematuria, absence of enlarg-
ing perinephric hematoma on ultrasound examination,
absence of recurrent need for erythrocyte administration,
and absence of need for subsequent renal surgery to stop
bleeding.
Embolization was performed under local anesthesia and
through the common femoral artery. The procedure started
with ﬂush aortogram for evaluation of extrarenal arterial feed-
ers to the tumor. Afterward, selective renal artery catheteriza-
tion was performed using 5 French Cobra (C2), RDC or
Simmonds (S1) angiographic catheters. The feeding vessels of
the tumor were catheterized by microcatheter (2.4–2.8 French,Progreat, Terumo Co., Tokyo, Japan) introduced coaxially
through the diagnostic catheter. The catheter tip was placed
distal to the renal artery branches supplying normal paren-
chyma. Embolization was performed with polyvinyl alcohol
particles (PVA) 150–250 and 300–500 lm, (Contour, Target,
Boston Scientiﬁc) respectively, to block the tumor periphery.
Larger proximal arteries and the pseudoaneurysms were
embolized lastly by 20–25% NBCA/lipiodol mixture (Fig. 1).
Antibiotic prophylaxis (cefuroxime intravenous infusion
(IVI) 1.5 g plus and metronidazole IVI 500 mg) was routinely
given just before and continued 48 h after the procedure.
Patients were routinely treated with nonsteroidal anti-inﬂam-
matory drugs (NSAID) during hospitalization.
Nephrectomy was performed for one patient, 5 weeks after
embolization for radical treatment of the mass. The other 7
patients underwent outpatient follow-up examinations, urinal-
ysis and estimation of serum creatinine level by an urologist
every 3 months in the ﬁrst year, and once a year thereafter
for 12–40 months (mean, 24 ± 4 months). Unenhanced and
enhanced CT was performed 3 months after embolization to
detect remnants of the angiographic component of the AML.
Re-embolization was considered if the ﬁrst embolization was
incomplete, or follow-up CT imaging showed residual vascu-
larization of AMLs. In the second session, we used small sized
PVA particles only for embolization, because most of the
residual arteries were small sized. The second follow up CT
was performed six months after total devascularization of
the AML. Only 3 patients performed a third CT after
12–18 months.
3. Results
The tumor was bilateral in 6 patients (75%) who had TS, and
unilateral in the other 2 patients with sporadic type of AML.
Only the ruptured tumors were included in this work. The size
of ruptured AMLs ranged from 5 to 18 cm measured in the
largest diameter on CT obtained before angiography (Table 1).
Angiography showed tortuous and stretched vessels in all the 8
ruptured AMLs and aneurysmal dilatation in 7 (88%). We
found solitary aneurysm in 4 AMLs and 2 aneurysms were
identiﬁed in the other 3 AMLs. The aneurysm size ranged from
1 to 3.5 cm. A single arterio-venous shunting was found in one
patient. Two to four arteries were embolized in each ruptured
AML (mean 2.6 arteries/tumor). Twenty-ﬁve feeding arteries
were embolized, which consisted of 3 segmental, 8 proximal
interlobar, 12 distal interlobar, and 2 renal capsular arteries.
Complete immediate devascularization of the tumor vessels
was achieved in 5 patients (62.5% primary technical success
rate), while subtotal devascularization was done in the remain-
ing 3 patients. The latter group was treated on emergency
bases and we found involvement of multiple interlobar
branches that made total embolization lengthy (in patients
with bad general condition) and carries high risk of major
renal ischemia.
No major complications or deaths occurred during or after
the procedures. Signs of post-embolization syndrome were
observed in 5 (62.5%) patients; including fever, pain, nausea
and sometimes vomiting. All were treated conservatively with
successful disappearance of these symptoms within 2–5 days.
Non-targeted embolization was documented in two patients
due to backﬂow of the embolization particles, but no
Fig. 1 TS-associated type of AML in a female patient presented with severe hematuria. (a) Contrast enhanced axial CT showing left
renal angiomyolipoma with extensive hypervascularity and central aneurysms. (b) Coronal MIP image showing the longitudinal extension
of the AML and the aneurysmal vessels (arrow head). (c) Catheter angiogram showing tumor hypervascularity and lobulated aneurysm
(arrow head). (d) Selective catheterization of one of the supplying branches with a microcatheter. (e) Postembolization angiogram showing
devascularization of the mass with good perfusion of the distal normal renal parenchyma. (f) Axial CT performed 6 months after
embolization showing signiﬁcant reduction of the tumor size and ﬁlling of its arterial supply (arrow) and aneurysm (arrow head) with
NBCA/lipiodol mixture.
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follow up laboratory studies. None of our patients developed
recurrence of bleeding (clinical success rate 100%) or required
further emergency surgery to stop bleeding.
Mean hospitalization was 5 (range 3–12) days. A second
session of elective embolization was performed for 3 patients,
13–15 weeks after the ﬁrst session, either due to subtotal devas-
cularization (n= 2) of the AML on the postprodedural con-
trol angiogram, or enhancement of the angiographic
component of the AML on follow up CT (n= 1). Total angio-
graphic devascularization was achieved in all patients (Second-
ary technical success rate 100%).
Follow-up CT for 7 patients after 3 months showed no
tumor growth, and the largest diameter of the tumors had
decreased 10–35% (mean reduction, 25%) after 3 months.
After 6 months of total devascularization, CT showed success-
ful devascularization of all AMLs with tumor length reduction
25–60% (mean reduction, 41%) (Table 1).
4. Discussion
Symptoms of AMLs uncommonly occur in lesions measuring
less than 4 cm in opposite to larger ones, of which 80–90%
are becoming symptomatic (6). We found that true in our
patients, as all of them had AMLs larger than 4 cm. TheTS-associated type represented 75% of all cases in our study
that adds conﬁrmation of its more aggressive nature than the
sporadic tumor type (7). Two morbidities are responsible for
AMLs bleeding. The ﬁrst is development of micro and macro-
aneurysms as the blood vessels within AMLs are abnormal
with no internal elastic lamina. These aneurysms may rupture
causing perinephric or retroperitoneal life-threatening hemor-
rhage. The presence of macroaneurysms in 88% (7/8) of the
examined ruptured AMLs supports the strong association
between aneurysm formation and bleeding, that was described
by Yamakado et al. in 2002 (8). Also, Rimon et al. (9) investi-
gated the correlation between symptoms and vascularity based
on digital subtraction angiography (DSA) and computerized
tomography (CT). They found that large AMLs with minimal
vascularity were less likely to bleed (9). The second uncommon
morbidity issue associated with renal AMLs is the invasion of
normal renal tissue and pelvi-caliceal system, leading to renal
failure (10) and hematuria which occurred in only two of our
patients (25%).
The available treatments for AMLs include; open surgery
(tumerectomy, partial/total nephrectomy) (11–15), laparo-
scopic and robotic surgery (16,17), selective renal arterial embo-
lization (SAE) (18–24), radiofrequency ablation (25), and
laparoscopic cryoablation (26). Treatment of hemorrhagic
AML is a balance between the need to stop life-threatening
Table 1 Summary of the clinical and angiographic data of the 8 patients.
Patient No. Age/gender Presentation Embolized
tumor length
(cm)
Number of
feeders
Presence of
aneurysm
Degree of
devascularization
Post-embolization results
Rebleeding Complications % Length
reduction
after 6 months
1 28/F Hematuria 11 4 2 Subtotal No PES/NTE (excised)
2 33/F Perinephric H. 9 3 1 Subtotal No PES 35
3 41/M Perinephric H. 18 4 2 Subtotal No PES 50
4 32/F Hematuria 11 3 1 Total No NO 40
5 52/M Perinephric H. 7 3 – Total No NO 35
6 43/F Perinephric H. 6 2 1 Total No NO 25
7 37/F Perinephric H. 10 4 1 Total No PES/NTE 60
8 22/F Perinephric H. 5 2 1 Total No PES 40
NTE, non-targeted embolization; PES, post-embolization syndrome; H, hemorrhage.
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as possible. Surgical procedure such as nephron sparing surgery
(NSS) eliminates the need for recurrent angiography and SAE,
however it has an overall complication rate of 12% including
5% risk of urinary ﬁstula (12). Also, the presence of retroperito-
neal hematomamay complicate surgery, increases the likelihood
ofmajor reduction of renal parenchyma, and total nephrectomy
is usually the end result. This makes surgery lose the advantage
of preservation of the renal parenchyma, which is crucial in
many cases such as previous renal insufﬁciency, a solitary kid-
ney, autosomal dominant polycystic kidney disease, or other
medical diseases. Chang et al. (27) studied 7 patients with rup-
tured angiomyolipomas who underwent urgent SAE within
the ﬁrst 24 h. Two patients underwent surgery because of persis-
tent hematoma that ended by total nephrectomy due to adhe-
sions and easy bleeding on touch. Furthermore, patients with
TS complex, associatedwith large sized, centrally placed (extend
to the hilum) and multiple angiomyolipomas have a limited role
of NSS (28). The advantages of SAE include; less invasive,
shorter hospital stay, negligible blood loss, and very low compli-
cation rate. The disadvantages include; non-eradication of the
disease (mean length reduction after 6 months is 42%), and
the need for repeated procedures. SAE is clearly beneﬁcial in
treating acute hemorrhage fromAMLs, allowing hemodynamic
stabilization of the patient and may obviate the need for subse-
quent surgery. We succeeded to stop bleeding in all of our
patients (clinical success 100%) and the reported efﬁcacy of
SAE in achieving hemostatis is 77–100% after a single session
of SAE (20–22,24,29). Total devascularization is notmandatory
in the critical stage as we had 100% clinical success, despite the
lower technical success of 62.5% for total devascularization.
The interventionalist should start embolization by selection of
the aneurysms-carrying arteries to get immediate hemostatsis.
If total devascularization is difﬁcult, carries risk of inadvertent
embolization, or needs long time in generally ill patient, subtotal
devascularization is better and completion of the embolization
could be performed 3 months thereafter simply and safely.
For SAE of AML, many embolizing materials were used
successfully such as absolute ethanol with or without lipiodol
(19,21,30), coils (5), PVA (18), or gelatin sponge (Gelfoam)
(18). Also, embosphere (31), onyx (32), and amplatzer vascular
plug (33) were used in case reports. Absolute ethanol ablation
was found effective in AML embolization (34), causingcomplete obliteration of aneurysms and the entire arteriocap-
illary system. The disadvantage of the use of absolute ethanol
ablation is the inability to visualize ethanol ﬂuoroscopically
causing fear of occlusion of non-target arteries by reﬂux. The
balloon occlusion technique may reduce the possibility of
non-targeted embolization, however, superselective catheteri-
zation of small renal arterial branches is technically difﬁcult
and may induce spasm (35), or occlusion of proximal non-tar-
geted arterial branches. Furthermore, Zerhouni et al. (36) and
Alder et al. (37) reported aneurysmal rupture during emboliza-
tion, with forced alcohol injection that increases intravascular
pressure and cause alcohol erosion of the aneurysm wall. Eth-
anol-iodized oil mixture has also been used in the embolization
of AMLs (18,19). The iodized oil has been thought to act as an
inert material, enhancing the embolic effect of the alcohol by
producing more homogeneous distribution of the agent and
increasing its contact time with tissue (35). The use of PVA
particles in embolization of AML did not gain a consensus.
It was reported that PVA particles do not penetrate the capil-
lary level (34), and most large vessels containing PVA particles
were incompletely occluded with particles embedded in the
walls with increased risk of aneurysm rupture if PVA particles
were used alone for AML embolization (38). Many interven-
tionlists have used coils for proximal arterial occlusion after
PVA injection to maximize the embolic effect, by rapid cessa-
tion of ﬂow in the targeted inﬂow artery (5). NBCA was used
in the current study instead of coils to augment the effect of
PVA and prevent recanalization. Despite the danger of cathe-
ter gluing, the risk of non-target embolization, and the need
for higher experience, we have not witnessed any signiﬁcant
problem with this cheap embolic material. NBCA/lipiodol
mixture provides total embolization of the proximal arteries
and ﬁlls the irregular shaped aneurysmal dilatations, prevent-
ing recanalization or aneurysm re-rupture.
SAE is a minimally invasive procedure, but it is not devoid
of complications. The most common complication is the
postembolization syndrome reported in up to 85% of cases
in previous studies (39,40), and in 62.5% (5/8) of the current
study. Other rare complications after SAE such as abscess for-
mation (41), pulmonary hypertension (42), lipiduria (43),
liquid necrosis of the AML (44), moderate pleural effusion
(19), and non-targeted embolization of renal tissue (23) have
been reported in the literatures. Non-targeted embolization
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with normal renal function as we noted in two of our patients
with multiple small feeders of the AML.
With conventional unenhanced and enhanced CT in the fol-
low-up period after embolization, we found only 41% mean
reduction in tumor size on CT performed 6 months after com-
plete embolization, as have other investigators (4,19,44). There
was no rebleeding in any of our patient, because we did not
wait for clinical recurrence in patients underwent subtotal
devascularization of the AMLs or showed enhanced angio-
graphic component on the ﬁrst follow up CT. We performed
the second diagnostic angiography and embolization
13–15 weeks after the ﬁrst session for total eradication of the
angiographic component. Lee et al. (19) reported a re-
embolization rate of 15.3% for treating AMLs with recurrent
hemorrhage, or recurrence of symptoms within a mean follow-
up time of 3 years. Kothary et al. (21) reported that after SAE
no recurrences occurred in patients with sporadic AMLs,
whereas 42.9% of TS-AMLs (9 of 21) showed recurrence. In
Tso et al.’s (24) series, 1 patient required reembolization for
treating a recurrence of symptomatic AML 16 months after
the ﬁrst treatment.
The most important limitation of our study is the small
series of patients with relatively short follow-up, which made
statistical analysis impossible. This is due to rarity of the
lesions and missing of many patients after short time of their
improvement.
Conclusion: SAE is effective and safe treatment for patients
with ruptured renal AMLs. Embolization of the aneurysmal
vessels should be the target in the acute stage with or without
total devascularization of the AML. NBCA/lipiodol mixture
could be used safely and effectively to augment the action of
PVA particles and prevent proximal arterial recanalization.
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